Technical Analysis for GLAXF - GlaxoSmithKline Plc

Grade Last Price % Change Price Change
grade B 19.9 0.51% 0.1000
GLAXF closed up 0.51 percent on Friday, August 16, 2019, on 18 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical GLAXF trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Strong but Oversold Other 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish 0.51%
Narrow Range Bar Range Contraction 0.51%
Gapped Down Weakness 0.51%
Oversold Stochastic Weakness 0.51%
Fell Below 50 DMA Bearish -0.50%

Older signals for GLAXF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology; and strategic alliance with Merck KGaA to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein immunotherapy. GlaxoSmithKline plc also has a joint research collaboration with Fimbrion Therapeutics Inc. to develop a small molecule candidate for the treatment and prevention of urinary tract infections. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Health Pharmaceutical Industry Pharmaceutical Industry In China Pharmaceutical Products Immunotherapy Hiv Asthma Rare Diseases Urinary Tract Infections Consumer Healthcare Products Decongestants Diclofenac
Is GLAXF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.3
52 Week Low 18.14
Average Volume 4,362
200-Day Moving Average 19.799
50-Day Moving Average 20.0874
20-Day Moving Average 20.3899
10-Day Moving Average 20.1173
Average True Range 0.2912
ADX 21.1
+DI 36.883
-DI 27.2054
Chandelier Exit (Long, 3 ATRs ) 20.4264
Chandelier Exit (Short, 3 ATRs ) 20.6736
Upper Bollinger Band 21.2006
Lower Bollinger Band 19.5792
Percent B (%b) 0.2
BandWidth 7.951976
MACD Line -0.0791
MACD Signal Line 0.0174
MACD Histogram -0.0965
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.1175
Resistance 3 (R3) 20.1250 20.0600 20.0813
Resistance 2 (R2) 20.0600 20.0046 20.0563 20.0692
Resistance 1 (R1) 19.9800 19.9704 19.9475 19.9725 20.0571
Pivot Point 19.9150 19.9150 19.8988 19.9113 19.9150
Support 1 (S1) 19.8350 19.8596 19.8025 19.8275 19.7429
Support 2 (S2) 19.7700 19.8254 19.7663 19.7308
Support 3 (S3) 19.6900 19.7700 19.7188
Support 4 (S4) 19.6825